{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T09:43:21Z","timestamp":1789638201758,"version":"4.0.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL107794"],"award-info":[{"award-number":["HL107794"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.jhep.2014.04.009","type":"journal-article","created":{"date-parts":[[2014,4,21]],"date-time":"2014-04-21T22:30:23Z","timestamp":1398119423000},"page":"358-365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Perilipin-5 is regulated by statins and controls triglyceride contents in the hepatocyte"],"prefix":"10.1016","volume":"61","author":[{"given":"C\u00e9dric","family":"Langhi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler J.","family":"Marquart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan M.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"Bald\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2014.04.009_b0005","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.bbalip.2009.04.002","article-title":"PAT proteins, an ancient family of lipid droplet proteins that regulate cellular lipid stores","volume":"1791","author":"Bickel","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhep.2014.04.009_b0010","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.tem.2011.03.008","article-title":"Oxidative tissue: perilipin 5 links storage with the furnace","volume":"22","author":"Wang","year":"2011","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/j.jhep.2014.04.009_b0015","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1194\/jlr.M500203-JLR200","article-title":"PPARalpha activation increases triglyceride mass and adipose differentiation-related protein in hepatocytes","volume":"47","author":"Edvardsson","year":"2006","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhep.2014.04.009_b0020","doi-asserted-by":"crossref","first-page":"14232","DOI":"10.1074\/jbc.M601682200","article-title":"MLDP, a novel PAT family protein localized to lipid droplets and enriched in the heart, is regulated by peroxisome proliferator-activated receptor alpha","volume":"281","author":"Yamaguchi","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.04.009_b0025","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.2337\/db06-0399","article-title":"OXPAT\/PAT-1 is a PPAR-induced lipid droplet protein that promotes fatty acid utilization","volume":"55","author":"Wolins","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.jhep.2014.04.009_b0030","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.bbalip.2006.11.011","article-title":"LSDP5 is a PAT protein specifically expressed in fatty acid oxidizing tissues","volume":"1771","author":"Dalen","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jhep.2014.04.009_b0035","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1194\/jlr.M038992","article-title":"Fatty acids regulate perilipin5 in muscle by activating PPARdelta","volume":"54","author":"Bindesboll","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhep.2014.04.009_b0040","doi-asserted-by":"crossref","first-page":"23852","DOI":"10.1074\/jbc.M111.328708","article-title":"Perilipin 5, a lipid droplet-binding protein, protects heart from oxidative burden by sequestering fatty acid from excessive oxidation","volume":"287","author":"Kuramoto","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.04.009_b0045","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1194\/jlr.M034710","article-title":"Cardiac-specific overexpression of perilipin 5 provokes severe cardiac steatosis via the formation of a lipolytic barrier","volume":"54","author":"Pollak","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhep.2014.04.009_b0050","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1194\/jlr.M032466","article-title":"Cardiomyocyte-specific perilipin 5 overexpression leads to myocardial steatosis and modest cardiac dysfunction","volume":"54","author":"Wang","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhep.2014.04.009_b0055","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s10620-012-2118-3","article-title":"Lipid-lowering agents in nonalcoholic fatty liver disease and steatohepatitis: human studies","volume":"57","author":"Nseir","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2014.04.009_b0060","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1124\/pr.108.00001","article-title":"Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis","volume":"60","author":"Anderson","year":"2008","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jhep.2014.04.009_b0065","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1185\/03007995.2013.855192","article-title":"Are statins \u2018IDEAL\u2019 for non-alcoholic fatty liver disease?","volume":"30","author":"Athyros","year":"2014","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jhep.2014.04.009_b0070","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s11883-012-0305-5","article-title":"Statins in nonalcoholic fatty liver disease and steatohepatitis: updated review","volume":"15","author":"Nseir","year":"2013","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jhep.2014.04.009_b0075","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jhep.2007.02.013","article-title":"Statins in non-alcoholic fatty liver disease and chronically elevated liver enzymes: a histopathological follow-up study","volume":"47","author":"Ekstedt","year":"2007","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2014.04.009_b0080","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1124\/jpet.302.1.232","article-title":"Atorvastatin treatment induced peroxisome proliferator-activated receptor alpha expression and decreased plasma nonesterified fatty acids and liver triglyceride in fructose-fed rats","volume":"302","author":"Roglans","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jhep.2014.04.009_b0085","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1476-511X-10-23","article-title":"Comparison of dietary control and atorvastatin on high fat diet induced hepatic steatosis and hyperlipidemia in rats","volume":"10","author":"Ji","year":"2011","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jhep.2014.04.009_b0090","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s11745-003-1093-x","article-title":"Pitavastatin ameliorates severe hepatic steatosis in aromatase-deficient (Ar\u2212\/\u2212) mice","volume":"38","author":"Egawa","year":"2003","journal-title":"Lipids"},{"key":"10.1016\/j.jhep.2014.04.009_b0095","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/emmm.201201228","article-title":"MiR-33 controls the expression of biliary transporters, and mediates statin- and diet-induced hepatotoxicity","volume":"4","author":"Allen","year":"2012","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jhep.2014.04.009_b0100","doi-asserted-by":"crossref","first-page":"E1293","DOI":"10.1210\/jc.2011-0149","article-title":"Fasting, but not exercise, increases adipose triglyceride lipase (ATGL) protein and reduces G(0)\/G(1) switch gene 2 (G0S2) protein and mRNA content in human adipose tissue","volume":"96","author":"Nielsen","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jhep.2014.04.009_b0105","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.jnutbio.2010.03.005","article-title":"ATGL and HSL are not coordinately regulated in response to fuel partitioning in fasted rats","volume":"22","author":"Bertile","year":"2011","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.jhep.2014.04.009_b0110","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1194\/jlr.M500459-JLR200","article-title":"PPARalpha activators and fasting induce the expression of adipose differentiation-related protein in liver","volume":"47","author":"Dalen","year":"2006","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jhep.2014.04.009_b0115","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/nar\/26.1.362","article-title":"Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL","volume":"26","author":"Heinemeyer","year":"1998","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.jhep.2014.04.009_b0120","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2014.04.009_b0125","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1172\/JCI2961","article-title":"Activation of cholesterol synthesis in preference to fatty acid synthesis in liver and adipose tissue of transgenic mice overproducing sterol regulatory element-binding protein-2","volume":"101","author":"Horton","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2014.04.009_b0130","doi-asserted-by":"crossref","first-page":"24714","DOI":"10.1074\/jbc.274.35.24714","article-title":"Sterol regulatory element-binding protein negatively regulates microsomal triglyceride transfer protein gene transcription","volume":"274","author":"Sato","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2014.04.009_b0135","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1210\/me.2007-0531","article-title":"Down-regulation of hepatic HNF4alpha gene expression during hyperinsulinemia via SREBPs","volume":"23","author":"Xie","year":"2009","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.jhep.2014.04.009_b0140","doi-asserted-by":"crossref","first-page":"10693","DOI":"10.1073\/pnas.94.20.10693","article-title":"Two sterol regulatory element-like sequences mediate up-regulation of caveolin gene transcription in response to low density lipoprotein free cholesterol","volume":"94","author":"Bist","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jhep.2014.04.009_b0145","doi-asserted-by":"crossref","first-page":"e36712","DOI":"10.1371\/journal.pone.0036712","article-title":"LSDP5 enhances triglyceride storage in hepatocytes by influencing lipolysis and fatty acid beta-oxidation of lipid droplets","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827814002621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827814002621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T17:12:43Z","timestamp":1748279563000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827814002621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S0168827814002621"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2014.04.009","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perilipin-5 is regulated by statins and controls triglyceride contents in the hepatocyte","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2014.04.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Association for the Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}